2010
DOI: 10.1016/j.amjcard.2009.12.020
|View full text |Cite
|
Sign up to set email alerts
|

Relation of Systemic Venous Return, Pulmonary Vascular Resistance, and Diastolic Dysfunction to Exercise Capacity in Patients With Single Ventricle Receiving Fontan Palliation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
42
1
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(49 citation statements)
references
References 29 publications
5
42
1
1
Order By: Relevance
“…[9][10][11] Peak power output was lower in Fontan patients than controls, and this was associated with a steep rise in SVP during exercise. In the two Fontan patients with greatest peak power output, the baseline and increase in SVP response was the least impaired and similar to controls (Figure 1).…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
See 1 more Smart Citation
“…[9][10][11] Peak power output was lower in Fontan patients than controls, and this was associated with a steep rise in SVP during exercise. In the two Fontan patients with greatest peak power output, the baseline and increase in SVP response was the least impaired and similar to controls (Figure 1).…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…A prior study showed diastolic dysfunction was present in 57% of Fontan patients assessed and was associated with a reduced peak VO 2 and peak power, and none showed the expected decrease in PVR on exercise. 9 NIRS derived StO 2 has been used as a marker of the adequacy of end-organ O 2 delivery relative to demand. 14 We demonstrated profound changes in StO 2 -C and StO 2 -R in Fontan patients at rest and during exercise.…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…Furthermore, although resting PAP and PVR may be normal in Fontan patients, exercise PVR response is demonstrably abnormal. 85 The application of pulmonary vasodilator therapy in these clinical scenarios is an area of active investigation. [86][87][88] Pulmonary vasodilator therapy may also have a role in the management of CHD patients with ventricular-arterial uncoupling despite an absence of pulmonary vascular disease or PH.…”
Section: Emerging Roles For Pulmonary Vasodilator Therapymentioning
confidence: 99%
“…Thus, different investigators using distinct populations and/or clinical and sports settings have proposed that the O 2 pulse can indirectly reflect stroke volume, so that both the maximum value and the curve shape, which are a function of CPET duration, will be directly associated with cardiac inotropism and lusitropism (4)(5)(6)(7)(8)(9)(10). In this context, several studies have shown that relatively low maximum O 2 pulse values are associated with a lower survival rate among middle-aged individuals as well as patients with heart failure (11,12), most likely reflecting impaired inotropic and/or lusitropic capacity and then disturbing the stroke volume response to exercise.…”
mentioning
confidence: 99%